Literature DB >> 6425222

Enhancement of host resistance against Listeria infection by Lactobacillus casei: role of macrophages.

K Sato.   

Abstract

Among the 10 species of the genus Lactobacillus, L. casei showed the strongest protective action against Listeria monocytogenes infection in mice. The activity of L. casei differed with regard to the dose of administration. The anti-L. monocytogenes resistance in mice intravenously administered 5.5 X 10(7), 2.8 X 10(8), or 1.1 X 10(9) L. casei cells was most manifest at ca. 2, 2 and 13, and 3 to 21 days after its administration, respectively. The growth of L. monocytogenes in the liver of mice injected with L. casei (10(7), 10(8), or 10(9) cells) 48 h after infection was suppressed, particularly when 10(8) or 10(9) L. casei cells were given 2 or 13 days before the induced infection, respectively. This suppression of L. monocytogenes growth was overcome by carrageenan treatment or X-ray irradiation. [3H]thymidine incorporation into the liver DNA increased 13 days after administration of L. casei, and augmentation of [3H]thymidine incorporation during 6 to 48 h after infection was dependent on the dose of L. casei. Peritoneal macrophage accumulation observed 1 to 5 days after intraperitoneal injection of UV-killed L. monocytogenes was markedly enhanced when the mice were treated with L. casei cells 13 days before macrophage elicitation. Therefore, the enhanced host resistance by L. casei to L. monocytogenes infection may be mediated by macrophages migrating from the blood stream to the reticuloendothelial system in response to L. casei injection before or after L. monocytogenes infection.

Entities:  

Mesh:

Year:  1984        PMID: 6425222      PMCID: PMC263539          DOI: 10.1128/iai.44.2.445-451.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  The granulomatous inflammatory response. A review.

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

2.  Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.

Authors:  L Milas; N Hunter; H R Withers
Journal:  Cancer Res       Date:  1974-03       Impact factor: 12.701

3.  The effect of carrageenan on delayed hypersensitivity reactions.

Authors:  H J Schwartz; S Leskowitz
Journal:  J Immunol       Date:  1969-07       Impact factor: 5.422

4.  Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.

Authors:  G D Stockman; L R Heim; M A South; J J Trentin
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

5.  Differential effect of heterologous anti-lymphocyte serum on antibody-producing cells and antigen-sensitive cells.

Authors:  G Möller; C Zukoski
Journal:  J Immunol       Date:  1968-08       Impact factor: 5.422

6.  Activated macrophages in congenitally athymic "nude mice" and in lethally irradiate mice.

Authors:  C Cheers; R Waller
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

7.  Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum.

Authors:  J E Swartzberg; J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

8.  T cell dependence of macrophage activation and mobilization during infection with Mycobacterium tuberculosis.

Authors:  R J North
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

9.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection.

Authors:  R J North
Journal:  J Exp Med       Date:  1970-09-01       Impact factor: 14.307

View more
  7 in total

1.  Relationship of bacterial growth phase to killing of Listeria monocytogenes by oxidative agents generated by neutrophils and enzyme systems.

Authors:  R Bortolussi; C M Vandenbroucke-Grauls; B S van Asbeck; J Verhoef
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

2.  Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.

Authors:  H Tomioka; K Sato; H Saito
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

3.  Monoassociation with probiotic Lactobacillus delbrueckii UFV-H2b20 stimulates the immune system and protects germfree mice against Listeria monocytogenes infection.

Authors:  Liliane Martins dos Santos; Mônica Morais Santos; Humberto Pereira de Souza Silva; Rosa Maria Esteves Arantes; Jacques Robert Nicoli; Leda Quercia Vieira
Journal:  Med Microbiol Immunol       Date:  2010-09-14       Impact factor: 3.402

4.  Impact of lactobacilli on orally acquired listeriosis.

Authors:  Cristel Archambaud; Marie-Anne Nahori; Guillaume Soubigou; Christophe Bécavin; Laure Laval; Pierre Lechat; Tamara Smokvina; Philippe Langella; Marc Lecuit; Pascale Cossart
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

5.  Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits.

Authors:  M Ogawa; K Shimizu; K Nomoto; M Takahashi; M Watanuki; R Tanaka; T Tanaka; T Hamabata; S Yamasaki; Y Takeda
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

6.  Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice.

Authors:  S Miake; K Nomoto; T Yokokura; Y Yoshikai; M Mutai; K Nomoto
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

7.  Effect of fermented oatmeal soup on the cholesterol level and the Lactobacillus colonization of rat intestinal mucosa.

Authors:  G Molin; R Andersson; S Ahrné; C Lönner; I Marklinder; M L Johansson; B Jeppsson; S Bengmark
Journal:  Antonie Van Leeuwenhoek       Date:  1992-04       Impact factor: 2.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.